European Leukemia Trial Registry
Trial: LAM2006IR

More Details
Title Randomized Open Phase III Trial Testing Efficacy of Gemtuzumab Ozogamycin (MYLOTARG) Associated to Intensive Chemotherapy for Patients Aged Between 18-60 Years and Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Short Title LAM2006IR
Trialgroup NN
Type of Trial randomized, open-label
Disease Acute myeloic leukemia(AML) AML all subtypes without FAB M3
Age 18-60 years
Status Active
Start of Recruitment 11.03.2009
Shortprotocol Shortprotocol
Remark contacts see: http://clinicaltrials.gov/ct2/show/record/NCT00860639
created 16.07.2010 Johannes Kraus
changed 16.07.2010 Johannes Kraus
© 2006 ELIC European Leukemia Information Center (Dr. N. Gökbuget, Dr. S. Schäfer) | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org